Conserved allosteric inhibitory site on the respiratory syncytial virus and human metapneumovirus RNA-dependent RNA...

Area of Science:

• Virology
• Structural Biology
• Drug Discovery

Background:

• Respiratory syncytial virus (RSV) and human metapneumovirus (HMPV) cause severe respiratory illness in vulnerable populations.
• Small molecule inhibitors targeting viral polymerases are under development, but their mechanisms are often unclear.
• Understanding viral polymerase function is crucial for developing effective antiviral therapies.

Purpose of the Study:

• To identify and characterize a conserved inhibitory site on RSV and HMPV L polymerase proteins.
• To elucidate the mechanism of action of a novel dual-specificity inhibitor, MRK-1.
• To provide structural insights into viral polymerase inhibition for therapeutic development.

Main Methods:

• Cryo-electron microscopy (Cryo-EM) to determine structures of inhibitor-polymerase complexes.
• Biochemical and functional assays to assess inhibitor activity and mechanism.
• Resistance profiling and competition studies to map inhibitor binding sites.

Main Results:

• A conserved allosteric inhibitory site on RSV and HMPV L polymerases was identified.
• The dual-specificity inhibitor MRK-1 binds this site, inhibiting viral replication.
• Cryo-EM structures revealed how MRK-1 interacts with both viral polymerases.
• MRK-1 inhibits essential conformational changes for RNA synthesis initiation and elongation.
• The MRK-1 binding site is distinct from known capping inhibitor sites.

Conclusions:

• MRK-1 is a potent inhibitor targeting a conserved allosteric site on RSV and HMPV L polymerases.
• Structural and functional data provide a basis for optimizing dual RSV/HMPV inhibitors.
• This work deepens understanding of viral polymerase mechanisms and antiviral strategies.